MAGNETOM World
MAGNETOM World
  1. MAGNETOM World
  2. Virtual 11th MAGNETOM World Summit
  3. 11th MAGNETOM World Summit
  4. Women’s Health

Women’s Health

DENSE Trial - Implications for Breast Cancer Screening

Carla van Gils (University Medical Center, UMC Utrecht, The Netherlands)

Repetitive HR-MRI of the Breast at Intervals of Maximum 24 Months - a Way to Reduce Mortality ?

Uwe Fischer (Diagnostisches Brustzentrum Göttingen, BZG, Göttingen, Germany)

Implementing Abbreviated MRI Screening into a Breast Imaging Practice

Donna Plecha (Univ Hospitals Cleveland, USA)

Abbreviated Breast MRI. The Royal Melbourne Journey1

Angela Agostinelli (The Royal Melbourne Hospital, Parkville Victoria, Australia)

Treatment Response Assessment with MRI

Susan Weinstein (Penn Medicine, University of Pennsylvania Health System, Philadelphia, PA, USA)

Further Reading
Susan P. Weinstein, Katrina Korhonen, Claire Cirelli, Mitchell D. Schnall, Elizabeth S. McDonald, Austin R. Pantel, Samantha Zuckerman, Ari Borthakur, Emily F. Conant. Abbreviated Breast Magnetic Resonance Imaging for Supplemental Screening of Women With Dense Breasts and Average Risk. J Clin Oncol 38, September 15, 2020: DOI https://doi.org/10.1200/JCO.19.02198.


MRI in Breast Cancer: From Bench to Bedside & Beyond. MRI-derived Parameters for Hormone Receptors

Katja Pinker-Domenig (Memorial Sloan-Kettering Cancer Center, New York, NY, USA)

Graphic Recordings of lectures and sessions

Graphic Recording Women's Health

Women’s Health

The herein illustrated statements made by Siemens Healthineers’ customers are based on their own and discrete opinion. The speaker is responsible for obtaining permission to use any previously published figures or tables. The speaker is also responsible for obtaining permission to reproduce any photograph showing recognizable persons.
1
Some products/features (here mentioned) are not necessarily commercially available in all countries. Due to regulatory reasons their availability cannot be guaranteed. Please contact your local Siemens Healthineers organization for further details.
2
The MRI restrictions (if any) of the metal implant must be considered prior to patient undergoing MRI exam. MR imaging of patients with metallic implants brings specific risks. However, certain implants are approved by the governing regulatory bodies to be MR conditionally safe. For such implants, the previously mentioned warning may not be applicable. Please contact the implant manufacturer for the specific conditional information. The conditions for MR safety are the responsibility of the implant manufacturer, not of Siemens Healthineers.
3
MR scanning has not been established as safe for imaging fetuses and infants less than two years of age. The responsible physician must evaluate the benefits of the MR examination compared to those of other imaging procedures.
4
Work in progress: the application is currently under development and is not for sale in the U.S. and in other countries. Its future availability cannot be ensured. Note: This feature may not be available in all regions/countries at the time of publication.
5
The product is not for sale in the U.S. Its future availability cannot be guaranteed.